Scarica l'app Stockscreener
5.87
6.53%
0.36
Dopo l'orario di chiusura:
5.85
-0.02
-0.34%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$5.51
Aprire:
$5.44
Volume 24 ore:
118.06K
Relative Volume:
0.13
Capitalizzazione di mercato:
$87.95M
Reddito:
$44.52M
Utile/perdita netta:
$-2.86M
Rapporto P/E:
-30.70
EPS:
-0.1912
Flusso di cassa netto:
$4.75M
1 W Prestazione:
+7.31%
1M Prestazione:
+92.46%
6M Prestazione:
+195.72%
1 anno Prestazione:
+15.32%
Intervallo 1D:
$5.44
$5.96
Intervallo di 1 settimana:
$5.03
$5.96
Portata 52W:
$1.85
$6.265
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
Nome
Cumberland Pharmaceuticals Inc
Settore
Telefono
615-255-0068
Indirizzo
1600 WEST END AVENUE, NASHVILLE,, TN
Compare CPIX vs TAK, HLN, TEVA, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
5.87 | 82.56M | 44.52M | -2.86M | 4.75M | -0.1912 |
TAK
Takeda Pharmaceutical Co Adr
|
16.25 | 52.07B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.29 | 41.28B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.07 | 39.78B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
81.32 | 33.57B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
568.43 | 24.02B | 3.17B | 1.29B | 1.01B | 27.09 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2012-11-12 | Reiterato | UBS | Neutral |
| 2011-02-01 | Reiterato | UBS | Neutral |
| 2010-12-16 | Downgrade | UBS | Buy → Neutral |
| 2010-08-17 | Downgrade | Jefferies | Buy → Hold |
| 2010-08-17 | Reiterato | Morgan Joseph | Buy |
| 2010-08-17 | Reiterato | UBS | Buy |
| 2010-05-14 | Reiterato | Morgan Joseph | Buy |
Mostra tutto
Cumberland Pharmaceuticals Inc Borsa (CPIX) Ultime notizie
Cumberland Pharmaceuticals jumps on $100M Apotex transaction - MSN
Cumberland Pharmaceuticals (CPIX) to sell U.S. brands to Apotex for $100M - Stock Titan
Cumberland outlines $100M Apotex deal while shifting to development-focused strategy - MSN
Cumberland Pharmaceuticals Inc. Q1 2026 Financial Results: Revenue, Expenses, and Company Overview - Minichart
$100M Apotex deal to reshape Cumberland (CPIX) into development player - Stock Titan
MSN Money - MSN
What Cumberland (CPIX) does that creates lasting value (Slight Dip) 2026-05-08Trade Entry Signals - Newser
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q1 2026 Earnings Call Transcript - Insider Monkey
Cumberland Pharmaceuticals Divests US Portfolio to Apotex for $100 Million - HarianBasis.co
Cumberland Pharmaceuticals Pivots After Transformational Apotex Deal - TipRanks
Cumberland Posts Loss in Q1 Amid $100M Apotex Deal Plan - Yahoo Finance
Cumberland Pharmaceuticals Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Cumberland: Q1 Earnings Snapshot - theheraldreview.com
Cumberland Pharmaceuticals (NASDAQ:CPIX) Issues Earnings Results - MarketBeat
Cumberland Pharmaceuticals Sells FDA-Approved Brands for $100 Million to Apotex, Reports Q1 2026 Financial Results and Focuses on Orphan Drug Pipeline 1 - Minichart
Cumberland Pharmaceuticals Q1 Earnings Call Highlights - MarketBeat
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln - TradingView
Cumberland Pharmaceuticals Inc. (CPIX) Stock Falls on Q1 2026 Earnings - Quiver Quantitative
CPIX: $100M Apotex deal and FDA approvals mark a strategic pivot to pipeline innovation - TradingView
Earnings call transcript: Cumberland Pharmaceuticals Q1 2026 shows mixed results - Investing.com
Cumberland Pharmaceuticals reports Q1 2026: $9.1M revenue, $3.3M net loss, Strategic Transaction announced - TradingView
Full Transcript: Cumberland Q1 2026 Earnings Call - Benzinga
Cumberland Pharmaceuticals (CPIX) sets $100M brand sale as Q1 2026 turns to loss - Stock Titan
$100M Apotex deal would leave Cumberland focused on orphan drugs - Stock Titan
CUMBERLAND PHARMACEUTICALS REPORTS Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE - Yahoo Finance
Apotex Affiliate to Acquire Cumberland Pharmaceutical Portfolio for $100M - HarianBasis.co
Cumberland Pharmaceuticals (CPIX) Integrates Commercial Business with Apotex - Insider Monkey
Q&A: A.J. Kazimi, Cumberland Pharmaceuticals - Nashville Post
Cumberland Pharmaceuticals (CPIX.US) will release its earnings report after the market closes on May 5. - Moomoo
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE - Weekly Voice
After the bell May 5: Cumberland to host Q1 update at 4:30 ET - Stock Titan
Cumberland Pharmaceuticals (CPIX) Expected to Announce Earnings on Tuesday - MarketBeat
RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights - Sahm
Cumberland Shareholders Back Board, Auditor and Pay Policies - The Globe and Mail
Cumberland Pharmaceuticals Inc. Files 8-K Report with SEC Detailing Company Information and Shareholder Vote Results - Minichart
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Passes Above 200 Day Moving AverageHere's What Happened - MarketBeat
Cumberland Pharmaceuticals shareholders approve board nominees and other proposals - Investing.com
Cumberland Pharmaceuticals Shares Surge 80 Percent After Apotex Deal - HarianBasis.co
Shareholders at Cumberland (NASDAQ: CPIX) back board, auditor and pay - Stock Titan
Crude Oil Gains Over 1%; US Initial Jobless Claims Edge Higher - Sahm
Apotex inks strategic transaction with Cumberland Pharma - The Pharma Letter
Baker Donelson Represents Cumberland Pharmaceuticals in Strategic Transaction to Integrate Commercial Business with Apotex - Baker Donelson
Cumberland to sell drug portfolio to Apotex for $100m - Pharmaceutical Technology
Cumberland Pharmaceuticals stock soars on $100M Apotex deal By Investing.com - Investing.com South Africa
CPIX Price Today: Cumberland Pharmaceuticals Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Cumberland shares soar on $100M deal announcement - Nashville Post
Cumberland Pharmaceuticals Inc Azioni (CPIX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.92%
4.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):